Mandate

Vinge advises FCG in connection with the acquisition of Algorithmica Research

Vinge has advised Bridgepoint and FCG in connection with the acquisition of Algorithmica Research AB, a software technology provider of risk management and quantitative financial analytical solutions for the financial services industry.

Through the acquisition, FCG, leading Northern European experts in Governance, Risk & Compliance (“GRC”) with a strong track record of providing new and customer centered services to clients in the finance and insurance sector, adds new capabilities to enhance and further expand its technology area and product offerings.

Vinge’s team consisted primarily of partner Daniel Rosvall and associates Michaela Cronemyr, Fredric Reissmüller, Carl Fredrik Wachtmeister (M&A), Lisa Hörnqvist (Commercial Agreements), Lisa Ullman (Employment), Nathalie Hughes (VDR-assistant) also partner Alber Wållgren along with associates Josefin Lanker and Hannes Pettersson (Banking & Financing).

 

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026